Navigation Links
Bharat Renewable Energy Forms Alliance With SG Biofuels to Deploy Jatropha Hybrids for Biodiesel in India
Date:8/9/2011

SAN DIEGO, Aug. 9, 2011 /PRNewswire/ -- Bharat Renewable Energy Ltd (BREL), a joint-venture of Bharat Petroleum, India's second largest petroleum company, has initiated a program with SG Biofuels (SGB) to develop and deploy elite hybrids of Jatropha for the production of biodiesel in India.

The program's first phase includes a crop development effort to produce high performing hybrid varieties of Jatropha adapted to unique growing conditions across the country.  Additional phases include the deployment of more than 86,000 acres of Jatropha using SGB's JMax™ hybrid seeds.

"With the genetic diversity of their Jatropha hybrid material combined with ability to produce large volumes of hybrid seed, SG Biofuels is an ideal partner to work with to successfully develop, validate and scale Jatropha as the primary source for biodiesel in India," said Mr. M.V. Radhakrishnan, chief executive officer of Bharat Renewable Energy Ltd.

SGB will draw from the advancements of its global JMax™ crop development centers where the company is optimizing elite hybrid varieties of Jatropha through a combination of molecular breeding and biotechnology.  The centers feature hybrid material from the company's germplasm library totaling more than 12,000 genotypes.  SGB will work with BREL to select, test and scale the highest yielding, most commercially viable hybrid varieties for growing regions in India, including the initial 86,000 acre deployment.

In December 2009, the Indian Government developed its National Policy on Biofuels targeting 20% blending of bioethanol and biodiesel into petrol and diesel markets.  Government policy stipulates the use of wastelands to cultivate non-edible oil seed plants without affecting food security.  According to the Asian Development Bank, the current cultivation of Jatropha and other non-edible oilseeds will need to increase by nearly 80 million acres to meet the nation's biodiesel targets.

"We look forward to working with BREL to develop a thriving Jatropha industry capable of meeting the country's significant demand for biodiesel," said Kirk Haney, president and chief executive officer of SG Biofuels.  "Our partnership is a great example how collaborations across the entire value chain – from crop science and agronomics to downstream refining and logistics – are the key to the successful scaling of Jatropha."

Jatropha is a non-edible shrub native to Central America.  Its seeds have high oil content, and can be processed to produce a high-quality energy feedstock.  It can be effectively grown on marginal lands that are considered undesirable for food crops.

SGB's integrated breeding and biotechnology approach forms the foundation for its JMax Jatropha Optimization Platform™, which draws from company's germplasm library, the sequence of the Jatropha genome, molecular markers and advanced biotech and synthetic biology tools to allow energy companies, governments and growers to select, test and scale elite Jatropha cultivars for unique growing conditions around the world.


'/>"/>
SOURCE SG Biofuels
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Honeywells Envergent Technologies Selected by Malaysian Company for Renewable Energy Project
2. DuPont Leader: Renewables at the Heart of Clean Technology Market Opportunity
3. Honeywells Envergent Technologies to Demonstrate Renewable Fuel for Heat & Power at Crane & Companys Massachusetts Headquarters
4. Department of Energy Funds SRI to Enhance Bioinformatics Tools for Renewable Energy Research
5. Verenium to Present at Piper Jaffray Sixth Annual Clean Technology & Renewables Conference
6. Rethinking renewables: A new approach to energy storage for wind and solar
7. Honeywell UOP Technology Selected to Support Conversion of Biomass to Fuel at California Renewable Energy Facility
8. Frost & Sullivan Recognizes Algasol Renewables for its Micro Algae Biomass Production System
9. DuPont Leader: Global Demand for Renewable Innovations Growing
10. Iowa Gains Momentum as Major Provider of Biorenewables
11. Growing Demand for DuPont Renewable Products Drives Global Commercialization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... -- WuXi AppTec, a leading global pharmaceutical, biotechnology ... today announced that it has acquired HD Biosciences ... contract research organization (CRO). After completion of acquisition, ... WuXi, and will continue to focus on growing ... acquisition will further strengthen WuXi,s R&D capability from ...
(Date:1/19/2017)... Switzerland (PRWEB) , ... January ... ... provider of advanced software solutions for pharmaceutical research and development (R&D), today ... expertise in omic data analysis and interpretation for the rapidly evolving field ...
(Date:1/19/2017)... and GAITHERSBURG, Md. , ... PIP) and Altimmune, Inc., a privately-held immunotherapeutics company ... a definitive agreement for the merger of PharmAthene ... investors include Novartis Venture Fund, HealthCap, Truffle Capital ... a fully-integrated and diversified immunotherapeutics company with four ...
(Date:1/19/2017)... Mass. , Jan. 19, 2017 AquaBounty ... focused on enhancing productivity in aquaculture and a majority-owned ... announces that it has completed the listing of its ... the equity subscription from Intrexon. "AquaBounty,s listing ... that will broaden our exposure to the U.S. markets ...
Breaking Biology Technology:
(Date:1/13/2017)... 2017 Sandata Technologies, LLC, a leading ... industry, including Electronic Visit Verification™ (EVV™), announced today ... as Senior Vice President of Product Management. ... homecare experience to Sandata, where he will be ... align Sandata,s suite of solutions with the needs ...
(Date:1/12/2017)... , January 12, 2017 A new report by Allied ... that the global biometric technology market is expected to generate revenue of $10.72 billion ... Continue Reading ... Allied Market Research ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
Breaking Biology News(10 mins):